Collaboration with SRI Provides Q BioMed Expertise in Formulation Development and Preclinical Work in...November-28-2018
Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22...October-26-2018
Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on...
RECENT SEC FILINGS
Description Form Date 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
2019-03-07 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 2019-03-01 8-K Current report 2019-01-07 EFFECT Notice of Effectiveness 2018-12-26 CORRESP Correspondence 2018-12-26 CORRESP Correspondence 2018-12-21 S-1/A General form for registration of securities under the Securities Act of 1933 2018-12-13 CT ORDER Confidential treatment order 2018-12-06 8-K Current report 2018-11-28 CORRESP Correspondence 2018-11-28